Patents by Inventor Andrew YUEH

Andrew YUEH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized anti-human neurotensin receptor 1 antibodies and their uses
    Patent number: 12091454
    Abstract: A humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. Also, a method for treating, prophylactic treating and/or preventing diseases and/or disorders caused by or related to NTSR1 activity and/or signaling, and a method or kit for detecting NTSR1 in a sample.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: September 17, 2024
    Assignees: DEVELOPMENT CENTER FOR BIOTECHNOLOGY, NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: Cheng-Chou Yu, Shu-Ping Yeh, Chao-Yang Huang, Szu-Liang Lai, Shih-Liang Hsiao, Mei-Ling Hou, Tzung-Jie Yang, Wei-Ting Sun, Liang-Yu Hsia, Andrew Yueh, Chiung-Tong Chen, Ren-Huang Wu, Pei-Shan Wu, Han-Shu Hu, Tzu-Chin Wu, Jia-Ni Tian
  • HUMANIZED ANTI-HUMAN NEUROTENSIN RECEPTOR 1 ANTIBODIES AND THEIR USES
    Publication number: 20240218062
    Abstract: A humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. Also, a method for treating, prophylactic treating and/or preventing diseases and/or disorders caused by or related to NTSR1 activity and/or signaling, and a method or kit for detecting NTSR1 in a sample.
    Type: Application
    Filed: December 28, 2022
    Publication date: July 4, 2024
    Applicants: DEVELOPMENT CENTER FOR BIOTECHNOLOGY, NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: CHENG-CHOU YU, SHU-PING YEH, CHAO-YANG HUANG, SZU-LIANG LAI, SHIH-LIANG HSIAO, MEI-LING HOU, TZUNG-JIE YANG, WEI-TING SUN, LIANG-YU HSIA, ANDREW YUEH, CHIUNG-TONG CHEN, REN-HUANG WU, PEI-SHAN WU, HAN-SHU HU, TZU-CHIN WU, JIA-NI TIAN
  • ANTI-HUMAN NEUROTENSIN RECEPTOR 1 ANTIBODY AND USE THEREOF
    Publication number: 20230183357
    Abstract: An isolated antibody, comprising: a heavy chain variable domain (VH) that is at least 75% identical to the amino acid sequence of SEQ ID NO: 1; and a light chain variable domain (VL) that is at least 75% identical to the amino acid sequence of SEQ ID NO: 2; wherein the antibody binds specifically to human neurotensin receptor 1 (hNTSR1).
    Type: Application
    Filed: June 9, 2021
    Publication date: June 15, 2023
    Inventors: Chuan Shih, Andrew Yueh, Ren-Huang Wu, Han-Shu Hu, Pei-Shan Wu, Zhi-Ping Yang, Yi-Yu Ke, Chiung-Tong Chen
  • COMBINATION THERAPY FOR HEPATITIS C VIRUS INFECTION
    Publication number: 20140127158
    Abstract: A method of treating hepatitis C virus infection, comprising administering to a subject in need thereof (a) an effective amount of at least one HCV inhibitor selected from the group consisting of an HCV NS3 inhibitor, an HCV NS5B inhibitor, ribavirin, and an IFN-?; and (b) an effective amount of an anti-HCV compound of formula (I).
    Type: Application
    Filed: November 6, 2013
    Publication date: May 8, 2014
    Applicant: National Health Research Institute
    Inventors: Andrew Yueh, Yu-Sheng Chao
  • Imidazolidinone and imidazolidinethione derivatives
    Patent number: 7939523
    Abstract: Imidazolidinone and imidazolinethione compounds of formula (I): wherein R1, R2, R3, A1, A2, X, Y, Z, m, n, p, x, and y are defined herein. Also disclosed is a method of treating hepatitis C virus infection with these compounds.
    Type: Grant
    Filed: January 5, 2009
    Date of Patent: May 10, 2011
    Assignee: National Health Research Institutes
    Inventors: Jyh-Haur Chern, Tsu-An Hsu, Iou-Jiun Kang, Li-Wen Wang, Chung-Chi Lee, Yen-Chun Lee, Yen-Shian Wu, Sheng-Ju Hsu, Yueh Andrew Yueh, Yu-Sheng Chao
  • IMIDAZOLIDINONE AND IMIDAZOLIDINETHIONE DERIVATIVES
    Publication number: 20090176766
    Abstract: Imidazolidinone and imidazolinethione compounds of formula (I): wherein R1, R2, R3, A1, A2, X, Y, Z, m, n, p, x, and y are defined herein. Also disclosed is a method of treating hepatitis C virus infection with these compounds.
    Type: Application
    Filed: January 5, 2009
    Publication date: July 9, 2009
    Applicant: National Health Research Institutes
    Inventors: Jyh-Haur Chern, Tsu-An Hsu, Iou-Jiun Kang, Li-Wen Wang, Chung-Chi Lee, Yen-Chun Lee, Yen-Shian Wu, Sheng-Ju Hsu, Yueh Andrew Yueh, Yu-Sheng Chao
  • METHOD FOR AMPLIFYING A FLAVIVIRUS cDNA IN A PROKARYOTIC CELL
    Publication number: 20090155854
    Abstract: The invention relates to a method for amplifying a functional flavivirus cDNA in a prokaryotic cell, such as E. coli. The method involves a modified flavivirus cDNA that has one or more silent mutations in one or more prokaryotic promoter regions within a flavivirus cDNA. The silent mutation decreases or abolishes the promoter activity from the prokaryotic promoter region without resulting in a change to the amino acid sequence encoded by the modified flavivirus cDNA as compared to that encoded by the flavivirus cDNA. The invention also relates to the functional flavivirus cDNA generated by the method, its complement, and its RNA transcript. The invention further relates to vectors, host cells and flavivirus related to the functional flavivirus cDNA.
    Type: Application
    Filed: November 5, 2007
    Publication date: June 18, 2009
    Applicant: National Health Research Institute (an institution of Taiwan, R.O.C.)
    Inventors: Andrew YUEH, Szu-Yuan PU, Chi-Chen YANG, Yu-Sheng CHAO